皓元医药 - Financials

皓元医药 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
+Revenue	2.3B	1.9B	1.4B	969.0M	635.0M	409.0M	300.0M	174.0M	117.0M	91.9M	67.1M	58.6M
Revenue Growth %	20.7%	38.4%	40.1%	52.6%	55.3%	36.3%	72.4%	48.7%	27.3%	37.0%	14.4%	--
Total Revenue	2.3B	1.9B	1.4B	969.0M	635.0M	409.0M	300.0M	174.0M	117.0M	91.9M	67.1M	58.6M
Cost Of Revenue	1.2B	1.0B	659.0M	445.0M	275.0M	175.0M	145.0M	83.3M	61.3M	63.5M	49.1M	44.8M
+Gross Profit	1.1B	849.0M	699.0M	524.0M	360.0M	234.0M	155.0M	90.7M	55.7M	28.4M	18.0M	13.8M
Gross Margin %	48.0%	45.2%	51.5%	54.1%	56.7%	57.2%	51.7%	52.1%	47.6%	30.9%	26.8%	23.5%
Total Operating Cost	2.0B	1.8B	1.2B	774.0M	499.0M	332.0M	282.0M	164.0M	99.9M	84.3M	65.5M	57.3M
Selling Expenses	210.0M	158.0M	110.0M	69.6M	49.0M	47.1M	32.3M	18.6M	9.1M	4.3M	2.7M	2.1M
Admin Expenses	235.0M	220.0M	169.0M	114.0M	65.9M	42.5M	54.3M	22.6M	27.9M	15.8M	12.0M	9.6M
Rd Expenses	227.0M	224.0M	202.0M	103.0M	64.8M	53.0M	35.4M	28.2M	--	--	--	--
Finance Expenses	34.5M	31.9M	-577,600	6.2M	8.8M	532,100	2.2M	463,000	507,500	361,100	464,200	272,400
+Operating Income	237.0M	128.0M	197.0M	210.0M	149.0M	84.4M	24.0M	16.2M	17.2M	7.6M	1.5M	1.9M
Operating Margin %	10.4%	6.8%	14.5%	21.7%	23.5%	20.6%	8.0%	9.3%	14.7%	8.3%	2.3%	3.3%
Non Operating Income	2.4M	2.3M	2.4M	122,800	282,900	139,400	64,800	400.00	3.1M	1.5M	1.5M	643,200
Non Operating Expenses	814,600	2.5M	408,800	356,200	358,300	165,000	25,000	2,000	107,300	2,400	13,600	15,100
Investment Income	-13.8M	-4.8M	16.1M	-118,600	1.5M	640,400	--	--	--	--	--	648,000
Fair Value Change Income	150,100	--	--	--	--	--	--	--	--	--	--	--
Asset Disposal Income	-567,200	62,700	-194,600	-36,900	-67,900	-14,800	-6,800	-7,800	--	--	--	--
Asset Impairment Loss	131.0M	84.0M	43.4M	29.1M	30.5M	11.4M	12.0M	10.3M	1.1M	230,200	1.2M	467,400
Other Income	29.4M	21.9M	23.0M	15.0M	11.7M	6.9M	6.2M	5.8M	--	--	--	--
Income Before Tax	238.0M	128.0M	199.0M	210.0M	149.0M	84.4M	24.0M	16.2M	20.2M	9.2M	3.0M	2.6M
Income Tax	40.4M	1.9M	7.0M	18.9M	20.2M	10.9M	5.6M	1.2M	2.2M	634,100	-152,100	250,400
+Net Income	198.0M	126.0M	192.0M	191.0M	128.0M	73.4M	18.4M	15.0M	18.0M	8.5M	3.2M	2.3M
Net Margin %	8.7%	6.7%	14.1%	19.7%	20.2%	18.0%	6.1%	8.6%	15.4%	9.3%	4.7%	4.0%
Net Income Attributable	202.0M	127.0M	194.0M	191.0M	128.0M	73.4M	18.4M	15.0M	18.0M	8.5M	3.2M	2.3M
Minority Interest	-3.7M	-1.1M	-2.1M	-407,900	--	--	--	--	--	--	--	--
Eps Basic	0.96	0.61	1.33	2.10	2.30	1.36	0.40	0.22	0.85	0.43	2.10	1.55
Eps Diluted	0.96	0.61	1.33	2.10	2.30	1.36	0.40	0.22	0.85	0.43	2.10	1.55

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
Cash And Equivalents	880.0M	484.0M	460.0M	1.0B	292.0M	203.0M	80.0M	49.7M	53.0M	18.7M	17.4M	3.2M
Trading Financial Assets	449.0M	--	17.2M	--	--	--	--	--	--	--	--	--
Accounts Receivable	522.0M	450.0M	337.0M	144.0M	80.3M	52.2M	39.0M	21.3M	25.4M	13.5M	6.6M	5.1M
Notes Receivable	20.7M	7.2M	347,300	2.1M	7.0M	1.8M	4.5M	4.8M	2.2M	1.8M	621,000	493,700
Notes And Accounts Receivable	543.0M	457.0M	337.0M	146.0M	87.3M	54.0M	43.5M	26.1M	27.7M	15.4M	7.3M	5.6M
Prepayments	13.2M	13.3M	15.7M	11.3M	6.1M	4.6M	4.3M	1.4M	9.1M	6.6M	4.9M	5.5M
Inventory	1.2B	1.1B	911.0M	352.0M	229.0M	150.0M	119.0M	92.6M	51.9M	24.0M	15.6M	15.9M
Total Current Assets	3.2B	2.2B	1.8B	1.6B	637.0M	425.0M	254.0M	173.0M	148.0M	65.5M	52.3M	31.5M
Long Term Equity Investment	127.0M	63.5M	67.9M	70.0M	72.3M	50.7M	--	--	--	--	--	--
Fixed Assets	--	875.0M	623.0M	230.0M	46.1M	22.8M	15.1M	11.9M	6.0M	6.3M	4.2M	1.4M
Fixed Assets Total	873.0M	875.0M	623.0M	230.0M	46.1M	22.8M	15.1M	11.9M	6.0M	6.3M	4.2M	1.4M
Construction In Progress	--	152.0M	247.0M	116.0M	23.8M	615,000	--	--	--	--	--	--
Construction In Progress Total	273.0M	152.0M	247.0M	116.0M	23.8M	615,000	--	--	--	--	--	--
Intangible Assets	114.0M	119.0M	101.0M	40.5M	31.7M	24.2M	24.7M	186,000	139,000	175,200	--	--
Long Term Deferred Expenses	130.0M	127.0M	129.0M	26.1M	24.2M	6.4M	1.5M	2.5M	178,500	430,100	409,800	208,600
Total Non Current Assets	2.3B	2.0B	1.8B	794.0M	220.0M	117.0M	51.0M	18.7M	7.8M	8.9M	5.1M	3.0M
Total Assets	5.5B	4.2B	3.6B	2.4B	857.0M	542.0M	304.0M	192.0M	156.0M	74.5M	57.4M	34.5M
Short Term Borrowings	539.0M	555.0M	229.0M	6.0M	76.9M	24.0M	38.2M	20.0M	20.0M	11.0M	4.0M	4.0M
Accounts Payable	335.0M	285.0M	287.0M	186.0M	68.9M	44.2M	31.3M	25.6M	9.7M	4.0M	7.6M	9.8M
Advance Receipts	--	--	--	--	--	20.9M	13.8M	16.3M	24.2M	16.1M	10.3M	3.0M
Contract Liabilities	70.6M	65.2M	58.7M	23.3M	47.7M	--	--	--	--	--	--	--
Total Current Liabilities	1.3B	1.2B	822.0M	322.0M	295.0M	124.0M	107.0M	75.6M	99.3M	41.8M	24.3M	24.8M
Long Term Borrowings	250.0M	229.0M	171.0M	--	--	--	--	--	--	--	--	--
Total Non Current Liabilities	1.3B	502.0M	444.0M	226.0M	34.3M	19.2M	19.5M	1.3M	880,000	--	200.00	--
Total Liabilities	2.6B	1.7B	1.3B	548.0M	329.0M	143.0M	127.0M	76.9M	100.0M	41.8M	24.3M	24.8M
Paid In Capital	211.0M	150.0M	107.0M	74.3M	55.7M	55.7M	48.0M	46.0M	22.2M	20.0M	2.3M	1.5M
Capital Reserve	1.7B	1.7B	1.6B	1.3B	237.0M	238.0M	75.3M	33.5M	10.2M	7.1M	19.2M	8,819
Surplus Reserve	24.9M	19.5M	19.5M	10.4M	8.1M	5.5M	341,600	341,600	341,600	--	712,100	590,200
Retained Earnings	821.0M	644.0M	554.0M	409.0M	224.0M	97.4M	52.2M	33.8M	22.4M	4.8M	10.5M	7.5M
Minority Equity	26.4M	17.2M	12.0M	14.1M	--	--	--	--	--	--	--	--
Equity Attributable	2.9B	2.5B	2.3B	1.8B	528.0M	400.0M	178.0M	115.0M	56.0M	32.7M	33.1M	9.7M
Total Equity	2.9B	2.5B	2.3B	1.8B	528.0M	400.0M	178.0M	115.0M	56.0M	32.7M	33.1M	9.7M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
Cash From Sales	2.3B	2.0B	1.3B	926.0M	676.0M	429.0M	299.0M	197.0M	122.0M	98.5M	78.4M	68.7M
Tax Refunds Received	29.7M	33.2M	69.0M	22.6M	9.5M	4.4M	2.8M	8.0M	144,500	--	--	--
Total Operating Cash Inflow	2.4B	2.0B	1.4B	1.0B	711.0M	442.0M	325.0M	211.0M	127.0M	103.0M	79.8M	69.4M
Cash Paid For Goods	848.0M	1.1B	962.0M	516.0M	337.0M	185.0M	154.0M	120.0M	79.3M	70.3M	49.3M	49.8M
Cash Paid To Employees	771.0M	777.0M	494.0M	268.0M	147.0M	120.0M	92.8M	50.8M	25.3M	16.4M	10.8M	9.3M
Taxes Paid	142.0M	82.4M	55.1M	76.0M	43.0M	27.6M	10.3M	7.5M	10.2M	2.1M	1.5M	1.2M
Total Operating Cash Outflow	2.0B	2.1B	1.6B	947.0M	594.0M	385.0M	296.0M	200.0M	140.0M	101.0M	83.8M	68.2M
Operating Cash Flow	382.0M	-63.6M	-240.0M	57.8M	117.0M	57.1M	28.4M	10.6M	-12.2M	1.8M	-4.0M	1.2M
Total Investing Cash Inflow	29.4M	930.0M	5.6B	1.8M	1,370	94,000	3,280	1,085	--	65,400	--	1.2M
Total Investing Cash Outflow	813.0M	1.3B	6.3B	308.0M	74.2M	70.6M	36.5M	12.8M	1.4M	3.7M	1.6M	3.4M
Investing Cash Flow	-784.0M	-329.0M	-713.0M	-306.0M	-74.2M	-70.5M	-36.5M	-12.8M	-1.4M	-3.7M	-1.6M	-2.2M
Cash From Borrowings	1.6B	735.0M	400.0M	4.0M	89.9M	24.0M	42.0M	20.0M	20.0M	11.0M	6.0M	4.0M
Dividends And Interest Paid	47.0M	64.5M	47.1M	1.8M	2.6M	24.6M	3.0M	766,600	6.7M	3.9M	340,500	810,500
Debt Repayments	738.0M	296.0M	7.0M	80.9M	37.0M	38.2M	23.8M	20.0M	11.0M	4.0M	6.0M	1.0M
Total Financing Cash Inflow	1.6B	815.0M	442.0M	1.1B	89.9M	194.0M	63.0M	20.0M	65.4M	11.0M	26.0M	4.0M
Total Financing Cash Outflow	842.0M	406.0M	81.5M	129.0M	39.6M	62.8M	26.8M	20.8M	17.7M	7.9M	6.3M	1.8M
Financing Cash Flow	791.0M	409.0M	360.0M	1.0B	50.3M	131.0M	36.2M	-766,600	47.7M	3.1M	19.7M	2.2M
Net Change In Cash	398.0M	20.2M	-578.0M	752.0M	83.6M	119.0M	29.2M	-3.3M	34.3M	1.3M	14.1M	1.1M
Ending Cash Balance	873.0M	475.0M	455.0M	1.0B	282.0M	198.0M	79.0M	49.7M	53.0M	18.7M	17.4M	3.2M
Capex	304.0M	260.0M	581.0M	288.0M	71.2M	20.6M	35.4M	9.4M	1.4M	3.7M	1.6M	3.4M